Change - Announcement of Cessation::Resignation of Independent Director
Issuer & Securities
Issuer/ Manager
REVEZ CORPORATION LTD.
Securities
REVEZ CORPORATION LTD. - SGXE83751573 - RCU
Stapled Security
No
Announcement Details
Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
21-Jan-2023 12:43:26
Status
New
Announcement Sub Title
Resignation of Independent Director
Announcement Reference
SG230121OTHRASRB
Submitted By (Co./ Ind. Name)
Victor Neo
Designation
Executive Director, Chief Executive Officer and Deputy Board Chairman
Description (Please provide a detailed description of the event in the box below)
Resignation of Independent Director - Mr Chang Yew Kong.
This announcement has been prepared by Revez Corporation Ltd. ("Company") and its contents have been reviewed by the Company's sponsor, UOB Kay Hian Private Limited ("Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr Lance Tan, Senior Vice President at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.
Additional Details
Name Of Person
Chang Yew Kong
Age
67
Is effective date of cessation known?
Yes
If yes, please provide the date
21/01/2023
Detailed Reason (s) for cessation
Mr Chang Yew Kong decided to cease his directorship with the company due to poor health issue which will require him to lessen his workload.
Based on its enquiries, the Company's sponsor, UOB Kay Hian Private Limited, is satisfied that, saved as disclosed in this announcement, there are no other material reasons for the resignation of Mr Chang Yew Kong as an Independent Director of REVEZ Corporation Ltd.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/12/2019
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, Chairman of Remuneration Committee, Member of Audit and Risk Committee, Member of Nominating Committee
Role and responsibilities
Duties of an Independent Director, Chairman of Remuneration Committee and member of Audit and Risk Committee and Nominating Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Not Applicable
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Directorships
Past (for the last 5 years)
Center for Quantum Technologies, NUS
ZWEEC Analytics Pte. Ltd.
Present
Wizvision Pte. Ltd.
Tag Team Inc Pte. Ltd.
DSCO Group Holdings Pte. Ltd.
Endopil Pte. Ltd.
NACT Engineering Pte. Ltd.
Home Team Science and Technology Agency
Related Announcements
Related Announcements